Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
we already have a large contract with minimum amounts set.... it has to start hitting the qtrly's soon imo
??
What makes you think there will be a large contract coming? it's been 8 months and we haven't seen anything yet.
i doubt they let this die on a vine as they've been getting shares at .03 AND things should be looking up with the large contract (although we have yet to see any change in the Q's)
I'm curious to see if management keeps things current with reporting. If it does I have to think that is a good sign that things are moving forward. If not, as quiet as it's been we might have a difficult road ahead.
10q Out. Still doesn't appear those large contract revs are there? Maybe next Q
very interesting open, ->
Time & Sales
Price Size Exch Time
$0.0300 21,539 OTO 09:33:51
$0.0400 75,000 OTO 09:30:51
$0.0500 5,000 OTO 09:30:28
$0.0600 100,000 OTO 09:30:23
$0.0500 2,486 OTO 09:30:00
$0.0500 10,000 OTO 09:30:00
$0.0500 3,055 OTO 09:30:00
$0.0500 2,251 OTO 09:30:00
$0.0500 2,741 OTO 09:30:00
$0.0600 10,000 OTO 09:28:06
$0.0500 10,000 OTO 09:26:56
would be nice to get some news. the Q doesn't have much new other than there were 2 new lawsuits filed against the company this may. sales were 218k for Q1 this year compared to $150 in sales from Q1 last year.
would be nice to get some news. the Q doesn't have much new other than there were 2 new lawsuits filed against the company this may. sales were 218k for Q1 this year compared to $150 in sales from Q1 last year.
Agree. If volume comes this will take off nicely.
I've been bid sitting. I think this will go at some point
Good to see some volume yesterday. If we can get any on a Friday, maybe something is happening? Could it be more sales to the Saudia's?
Several Form 4's filed today. Thanks for the heads up Immie.
Link: http://ih.advfn.com/p.php?pid=news&symbol=NO%5ENANM
Nice write up of our deal, take a look.
http://www.tradearabia.com/news/HEAL_215159.html
I really like this part;
'We have been working diligently with our Saudi partners to form this strategic relationship, by establishing not only an office in Saudi Arabia, but also facilitating the manufacture of our products in that country,” said Edward J Suydam, president and CEO, Nano Mask.
'We are confident that our partners will meet or exceed the minimum sales requirements outlined in our agreement, as evidenced by the significant orders from the Middle East that we have already received,” he added
the Q will be due on may 15th. hopefully they keep current and file on time. beating all of last year's revenue in the first quarter would be huge. month and half waiting game. maybe we get some more news between now and then
We need to see some revenue figures. It should help the share price knowing that money is coming in. They took in 97K last year, I'd like to see double that for the first quarter. That should cover all expense and leave some money for future growth. If we can top $1mm this year that would be a great start and would set us up for a very strong growth going forward. 14MM the next 4 years plus any additional sales. The future looks bright.
Tamayz Medical, who are they? From what I could find out they are part of the "Alajaji Group" who are diversified in quite a few different businesses.
Real Estate
Medical Equipment
Medical Supplies
Medical Furniture
Hospital Catering
Computer Systems
It looks like they are the real deal and can handle the $13,000,000 deal without a problem. Don't know how management did it but we got a winner here.
Excellent post.
Let's look at what we have.
1.Our company pays a boat load of money to get the company current with it financials. Not an easy task for a pink sheet company.
2. Enters Into Exclusive Licensing and Manufacturing Agreement with Noble Fiber Technologies for Healthcare Products in the Middle East. Why did they do this?
3. This is why, Nanm enters into a five year distribution agreement with Tamayz Medical, Inc. (the distributor), a Middle Eastern medical products distributor based in Riyadh, Saudi Arabia . Tamayz has agreed to purchase a minimum of $13,000,000 of various NMI healthcare products. Really $15,000,000 over the next 5 years. An average of $3,000,000 per year for the next 5 years. Not bad for a company that basically had no sales over the past 4 years.
4. Look for other sales around the world. Nanm is selling the product that the world will need and need badly as viruses progress around the world. (It seems we are ahead of the curve with these products.)
5. What does the future hold? IMO more sales to start with and if things progress like I believe they will, someone with deep pockets buying us out. If that happens you're looking at a 20 bagger from today’s close. Talking about deep pockets a lot of people in Saudi Arabia have just that.
agreed, but I think this thing goes nowhere but up. Here's to a better day tomorrow. GL
today's trading was disappointing BUT the pr was GREAT... just wish it wasn't dumped in to
the K shows that officers/directors were issued stock throughout the past year for compensation and repayment of loans etc. I think NANM needs some good PR behind it and I still think a letter to shareholders would be a good place to start. I disagree that it's too expensive. it would cost $.75-$1 per s/h and the K says there are 2,300 shareholders. it would be a good start to reach out to a lot of people who probably gave up on this thing two years ago.
i've considered that some insiders..etc were granted shares in lieu of stuff....... 'could' be 1 of them needed cash... i suppose 'if' that's the case we should know in a few days
too bad too b/c we should have went over .10 IMO with this pr and volume
g/l
i dont know, it's the only explanation i can think of. 1.2MM in volume it's staying @ this level
why would they..... today's the type of pr that would entice me to add to my position ...............not sell
probably a lot of longs getting out on today's news
"In total, agreements with the distributor call for the purchase of a minimum of $15,300,000 of NMI products within five years.
"
somebody with a large position used the pr to dump IMO
1mm shares at the ask 56K at the bid at this point. I wonder what is keeping the price so low? It the buys continue we should be over .10 today.
Huge huge huge news for us
In total, agreements with the distributor call for the purchase of a minimum of $15,300,000 of NMI products within five years.
NA_NM, Nano Mask Enters Into Five Year $13,000,000 Middle East Distribution Agreement with Tamayz Medical
Press Release: Nano Mask Inc. – 3 minutes 45 seconds agoCompanies:Nano Mask, Inc.RELATED QUOTESSymbol Price Change
NANM.PK 0.045 -0.01
FISHKILL, N.Y., March 29, 2012 /PRNewswire/ -- Nano Mask Inc., (NMI) (NANM.PK), a materials technology development company focused on health and wellness related markets, today announced that it has entered into a five year distribution agreement with Tamayz Medical, Inc. (the distributor), a Middle Eastern medical products distributor based in Riyadh, Saudi Arabia . Tamayz has agreed to purchase a minimum of $13,000,000 of various NMI healthcare products fabricated with X-Static® antimicrobial yarn over five years in exchange for exclusive distribution rights in the Middle East. The agreement has a five year renewal option.
This agreement is separate from a previous distribution agreement with Tamayz which called for the purchase of $ 2,300,000 in NMI products over four years. In total, agreements with the distributor call for the purchase of a minimum of $15,300,000 of NMI products within five years.
The agreement calls for NMI to supply to the following products: hospital and surgical scrubs, patient gowns and pajamas, bedding (sheets, pillows, covers and liners), blankets, window and cubicle curtains, as well as X-Static Silver yarn fabric. The territory governed by the agreement includes the following countries: Saudi Arabia, Egypt, Libya, Algeria, Morocco, Jordan, Iraq, Lebanon, Bahrain, Yemen, Kuwait, Oman, Qatar and United Arab Emirates.
"We have been working diligently with our Saudi partners to form this strategic relationship, by establishing not only an office in Saudi Arabia, but also facilitating the manufacture of our products in that country."
Mr. Suydam added, "We are confident that our partners will meet or exceed the minimum sales requirements outlined in our agreement, as evidenced by the significant orders from the Middle East that we have already received."
About Nano Mask
Nano Mask Inc. (NMI) is a materials technology development, manufacturing and distribution company providing emergency life support and infection prevention products and solutions to a variety of market segments within the healthcare industry.
Forward-looking Statement
This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. Specifically, any unforeseen delays in manufacturing and distribution may affect the planned timeline for initiating actual sales of the product. NMI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the company could differ significantly from such forward-looking statements.
For further Information email:
Edward J. Suydam
President and CEO
Nano Mask Inc.
Eds@nmihealth.com
914-760-7857
Wow monster revenue news.. 10 cents coming?
LOOK @ that PR!!!
Too expensive. All they need to do is keep putting out updated PR's and the shareholders will find out.
would be a nice touch especially if pr'd for all to see
I think it would be a good idea to send a letter to all their shareholders and let them know what's gone on with the company over the past few years
Agreed, not too many watching this one....yet
after spending $300k to catch up on 4 years of audits NANM has filed on time for this year's 10K. that is good news which will go largely unnoticed
this seems key imo, "will permit us to enjoy exclusive manufacturing and distribution rights in the Middle East "
new site address but still looks like same content, http://nanoprotectionsolutions.com/
Nano Mask Enters Into Exclusive Licensing and Manufacturing Agreement with Noble Fiber Technologies for Healthcare Products in the Middle East
Press Release: Nano Mask Inc. – 46 minutes agoCompanies:Nano Mask, Inc.RELATED QUOTESSymbol Price Change
NANM.PK 0.045 +0.00
FISHKILL, N.Y., March 22, 2012 /PRNewswire/ -- Nano Mask Inc. (NMI), (OTCQB: NANM.PK - News), a health care company focused on materials technology development, manufacturing and distribution announced today, that it has entered into a five year (with a five year renewal option) licensing, manufacturing and distribution agreement with Noble Fiber Technologies LLC, a wholly owned subsidiary of Noble Biomaterials, Inc., whereby Nano Mask will license Noble's proprietary X-STATIC® antimicrobial fiber and yarn to fabricate customized healthcare fabrics and textiles and to further manufacture these materials into an extensive line of professional health care apparel and barrier products. The license gives NMI the right to fabricate, manufacture and distribute globally with exclusive distribution rights in the following countries: Saudi Arabia, Egypt, Libya, Algeria, Morocco, Jordan, Iraq, Lebanon, Bahrain, Yemen, Kuwait, Oman, Qatar, and UAE.
The scope of the license agreement will enable NMI to manufacture and distribute products using Noble's proprietary X-STATIC technology throughout the world. NMI is currently fabricating and manufacturing with Noble's antimicrobial materials at four international locations. NMI's market focus is on acute and extended care healthcare facilities which are witnessing an unprecedented demand for soft surface solutions which can help address the serious challenges of infection transmission from existing (unprotected) soft surfaces within health care facilities.
"This agreement solidifies our relationship with Noble and will permit us to enjoy exclusive manufacturing and distribution rights in the Middle East as well as non-exclusive rights in other countries," said Ed Suydam, President and CEO, Nano Mask. Mr. Suydam added, "We have already seen significant orders from the Middle East and expect to ramp up both production and sales of these products in the coming months."
About Nano Mask Inc.
Nano Mask, Inc. (NMI) is a materials technology development, manufacturing and distribution company providing emergency life support and infection prevention products and solutions to a variety of market segments within the healthcare industry.
About Noble Biomaterials Inc.
Noble Biomaterials, Inc. is a global leader in bacterial management solutions. Noble develops, manufactures, sells and markets advanced antimicrobial technologies designed to manage all forms of bacterial contamination for medical, defense, industrial and consumer markets.
Forward-looking Statement
This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. Specifically, any unforeseen delays in manufacturing and distribution may affect the planned timeline for initiating actual sales of the product. NMI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the company could differ significantly from such forward-looking statements.
For further Information email:
Edward J. Suydam
President and CEO
Nano Mask, Inc.
Eds@nanoprotectionsolutions.com
Today's news looks to be laying the ground work for future sales. NMI products are sure to be in demand, as long as we can get the word out and price it accordingly we could see some nice sales going forward. More in Saudi Arabia? I would love to see them elsewhere but I'm sure that takes time.
DBE, Yes it was a good buy at those levels.
really suprised by today's selloff.. i may avg down if i can find cash
If we can hold this price and get some news about sales we could be back over.10. Pending the size of the order we could see the teens.
yeah i know.. i was talking about the last 2-3 weeks... but thanks for setting me straight lol
Followers
|
13
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
405
|
Created
|
10/22/04
|
Type
|
Free
|
Moderators |
Level 2 View - Not Realtime!
Q. What is swine flu?
A. Swine influenza, or flu, is a contagious respiratory disease that affects pigs. It is caused by a type-A influenza virus. Outbreaks in pigs occur year-round.
The most common version is H1N1. The current strain is a new variation of an H1N1 virus, which is a mix of human and animal versions.
EMFP .49...this is damn important for EMFP...Itochu is an $85 BILLION Corp-worldwide...they will sell at least thru out Asia...not just Japan...as bird flu is becoming a very real threat over there. This is part 1...part 2 are the results of the military testing due soon...see next PR below this one...the testing is just pro forma IMO...this will be a helluva one two punch and should finally get EMFP moving:
B: Itochu Techno Chemical Obtains Regulatory Approval to Import and Sell Emergen
y Filtration Products' Respiratory Devices in Japan
HENDERSON, Nev., Oct 21, 2004 (BUSINESS WIRE) -- Emergency Filtration Products
Inc. (EFP) (OTCBB: EMFP) today announced that its partner, Itochu Techno
Chemical Inc., has obtained a Certificate of Import and a Certificate of Sale
from Koseisho (the Japanese Ministry of Health and Welfare, akin to the U.S.
FDA) to immediately begin importing and selling EFP's RespAide, Vapor Isolation
Valve and Series One Breathing Circuit Filter products in Japan.
EFP and Itochu Techno Chemical have been collaborating for over 18 months in
order to help bring EFP's products to market in Japan, as well as preparing a
feasibility study to expand distribution to other Asian countries, with possible
global expansion. After filing an application with Koseisho on Feb. 27, 2004,
the two companies began working on a distribution agreement that would govern
the sale of EFP products to Itochu Techno Chemical and other related companies.
EFP expects to enter into a long-term distribution agreement in the near future.
"We are extremely pleased to have our products cleared for launch in Japan,"
said Douglas K. Beplate, president, EFP. "We would like to thank our partners at
Itochu Techno Chemical for all of their hard work with regard to the application
made with Koseisho and especially with respect to their meticulous and
painstaking approach to assuring the success of our products in the Japanese
market place." Beplate went on to add, "EFP is highly confident that Itochu
Techno Chemical's expertise will not only pay off in the rapidly growing $300
million Japanese market for respiratory products, but will also lead to success
in other Asian countries and beyond."
Itochu Techno Chemical (http://www.techno-chemical.com/ is a subsidiary of
Itochu Corp.
Itochu Corp. (http://www.itochu.co.jp/main/index.html), one of the world's
largest trading companies with 2003 revenues in excess of $85 billion, ranked
11th in the world by revenues, according to Forbes magazine. Itochu is a
globally integrated corporation with offices in over 80 countries and operations
that cover a broad spectrum of industries.
About Emergency Filtration Products Inc.
EFP (http://www.emergencyfiltration.com/) is an air filtration products
manufacturer whose patented 2H Technology(TM) filter system has produced
filtration efficiencies of "greater than 99.99%" at a particulate size of 0.027
microns. Its initial products were developed for the medical market: the Vapor
Isolation Valve(TM) and RespAide(R) CPR Isolation Mask used for resuscitation of
respiratory/cardiac arrest cases; and the 2H Breathing Circuit Filter for
ventilators, respirators and anesthesia circuitry. Each has received FDA
approval. The company also markets an Automated External Defibrillator Prep Kit
featuring RespAide; and the NanoMask(R), a nanotechnology enhanced environmental
mask. In addition to filtration products, the company supplies Superstat(R), a
modified hemostatic collagen, to the U.S. military for surgery and extreme wound
care.
B: Center for Commercialization of Advanced Technology -- CCAT --
B: Center for Commercialization of Advanced Technology -- CCAT -- Awards Emergen
HENDERSON, Nev., Sep 14, 2004 (BUSINESS WIRE) -- Emergency Filtration Products,
Inc. (EFP) (OTCBB:EMFP) announces that it has been awarded a Prototype
Development/Testing/Evaluation Grant (PDT&E) to develop a testing protocol for
filter media on behalf of the U.S. Military. As part of this project, EFP will
begin testing its licensed nano-enhanced filter media at Edgewood Chemical
Biological Center in Edgewood, Maryland within the next few weeks. The testing
and evaluation process is expected to take approximately one month to complete,
following which (assuming positive testing results), EFP expects to sub-license
its nano-enhanced filter media to a Department of Defense approved manufacturer
to enhance existing filtration products that are currently used by the U.S. Air
Force, Army and Navy, as well as to commence development of new product
applications that will serve to better protect U.S. Military personnel.
"The award of the PDT&E grant from CCAT to develop a standard filter media
testing protocol for the U.S. Military is a milestone for our company," said
Douglas K. Beplate, President, EFP. "While we originally expected to begin
testing for the U.S. Air Force last month, we have been requested to have our
filter technology tested for all branches of the Military simultaneously." Mr.
Beplate went on to add, "We expect that the testing will not only prove to be
successful, but will also lead to a rapid commercialization of our licensed
nano-enhanced filter media technology which will assist all branches of the U.S.
Military - Army, Air Force and Navy - to incorporate our technology into
applications that will serve the U.S. Military worldwide."
For the past 18 months, EFP has been working in conjunction with U.S. Army
Research, Development & Engineering Command (RDECOM) to test its nano-enhanced
2H filter technology in order to accelerate the commercial development of a
number of filter technology applications and allow for rapid procurement by the
U.S. Department of Defense. RDECOM has been examining how to apply the company's
filter technology to a large number of potential applications, including, but
not limited to: biohazard masks, transportation (aircraft, tanks, armored
personnel carriers) and buildings (military, industrial, office and
residential). The program has conducted a number of cost and user needs
analyses, economic analyses and technical viability studies of EFP's proprietary
licensed 2H Filter technology. Over 1,000 potential applications of EFP's filter
technology have been identified by RDECOM.
About RDECOM:
http://www.rdecom.army.mil/index.html
MISSION -- Get the right integrated technologies into the hands of warfighters
quicker.
VISION -- To be recognized as the preeminent world leader in research,
development and engineering of systems, whose hallmark is transitioning the
right technology in the shortest time to our Soldiers.
INTENT -- The Commanding General of the U.S. Army Materiel Command (AMC)
established the U.S. Army Research, Development & Engineering Command (RDECOM),
as a new major subordinate command within AMC. This new command will restructure
core in-house capabilities now so we can fully exploit the enormous potential
that resides in research activities around the world. RDECOM will respond
rapidly by integrating, maturing and demonstrating emerging technologies to
field the right equipment, in the shortest time, for our Soldiers.
About ECBC:
http://www.ecbc.army.mil/
ECBC is the nation's principal research and development center for chemical and
biological defense. Tracing its roots back to 1917, ECBC leverages more than 85
years of experience with live agent to develop and enhance defense systems.
ECBC seeks opportunities to develop partnerships with industry, academia and
state and local governments to continue achieving major technological advances
for national defense, civilian protection and industrial competitiveness.
Complimenting these efforts, the Center offers several unique facilities that
provide full life-cycle support to chemical and biological protection, detection
and monitoring capabilities.
About CCAT:
The CCAT (http://www.ccatsandiego.org/index.shtml)- supported by Congress and
funded by the Department of Defense - is a public-private collaborative
partnership between academia, industry, and government. Partners include San
Diego State University (SDSU) Foundation and Entrepreneurial Management Center,
the University of California, San Diego (UCSD) Jacobs School and UCSD CONNECT,
and Lockheed Martin ORINCON Technologies, Inc. with support from the Space and
Naval Warfare Systems Center, San Diego. The consortium-style CCAT intends to
bridge the gap that exists between the generators of technology, the Department
of Defense and the commercial marketplace. EFP will also be working in
conjunction with the Office of Technology Transfer and Commercialization (OTTC)
at California State University, San Bernardino (http://ottc.csusb.edu/), a CCAT
partner on this project.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |